Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Arcus Biosciences, Inc. (RCUS)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Jun-05-23 | Mar-31-23 | Mar-05-23 | Jun-30-22 | Jun-05-22 | Mar-31-22 | Mar-05-22 |
| | 10-Q | 8-K | 10-Q | 8-K | 10-Q | 8-K | 10-Q | 8-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 386.2% | 0.0% | 324.0% | 0.0% | 355.6% | 0.0% | 338.9% |
| Gross profit | 100.0% | -286.2% | 100.0% | -224.0% | 100.0% | -255.6% | 100.0% | -238.9% |
| Selling, general and administrative | | | | | | | | |
| Research and development | 289.7% | | 324.0% | | 259.3% | | 338.9% | |
| General and administrative | 96.6% | 96.6% | 120.0% | 120.0% | 96.3% | 96.3% | 133.3% | 133.3% |
| EBITDA | -279.3% | -286.2% | -336.0% | -344.0% | -248.1% | -255.6% | -366.7% | -372.2% |
| Depreciation | 6.9% | | 8.0% | | 7.4% | | 5.6% | |
| EBIT | -286.2% | -286.2% | -344.0% | -344.0% | -255.6% | -255.6% | -372.2% | -372.2% |
| Pre-tax income | -255.2% | 0.0% | -312.0% | -328.0% | -248.1% | 0.0% | -372.2% | -383.3% |
| Income taxes | 3.4% | 0.0% | 8.0% | -8.0% | 0.0% | 0.0% | 5.6% | -5.6% |
| Net income | -258.6% | 0.0% | -320.0% | -320.0% | -248.1% | 0.0% | -377.8% | -377.8% |
|